Rohan Palekar
2021
In 2021, Rohan Palekar earned a total compensation of $4.9M as Chief Executive Officer at 89bio, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $254,250 |
|---|---|
| Option Awards | $3,392,295 |
| Salary | $565,000 |
| Stock Awards | $690,300 |
| Other | $10,157 |
| Total | $4,912,002 |
Palekar received $3.4M in option awards, accounting for 69% of the total pay in 2021.
Palekar also received $254.3K in non-equity incentive plan, $565K in salary, $690.3K in stock awards and $10.2K in other compensation.
Rankings
In 2021, Rohan Palekar's compensation ranked 2,676th out of 12,415 executives tracked by ExecPay. In other words, Palekar earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,676 out of 12,415 | 78th |
Division Manufacturing | 1,053 out of 5,505 | 81st |
Major group Chemicals And Allied Products | 413 out of 2,375 | 83rd |
Industry group Drugs | 360 out of 2,096 | 83rd |
Industry Pharmaceutical Preparations | 237 out of 1,546 | 85th |
Source: SEC filing on April 14, 2022.
Palekar's colleagues
We found two more compensation records of executives who worked with Rohan Palekar at 89bio in 2021.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020